EMA Authorised: Cegfila (previously Pegfilgrastim Mundipharma) (pegfilgrastim) — Mundipharma Corporation (Ireland) Limited

View source ↗

Summary

The EMA authorised the pegfilgrastim product Cegfila (Mundipharma) for marketing in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Febrile Neutropenia
• Neutropenia

Drugs mentioned

• Cegfila (pegfilgrastim)

Snippet

Status: Authorised. MAH: Mundipharma Corporation (Ireland) Limited. Decision date: 17/03/2026